Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Pandemic Has Left Nearly 43 Million Americans Without WorkPeople Are Avoiding the ER During COVID-19 Crisis at Their Peril: StudyAs Postponed Surgeries Resume, Can U.S. Hospitals Handle the Strain?Most Americans Still More Worried About COVID-19 Spread Than the EconomyBig Need for Blood Donations as Postponed Surgeries ResumeEmergency Transport Can Surprise Many With Big BillsOnly Half of Americans Say They'd Get a Coronavirus Vaccine: SurveyIf Prescribed Opioids for Pain, Ask Lots of Questions: FDAState Texting Bans Are Saving Teen Drivers' LivesMillions of Older Americans Can't Get Enough FoodLayoffs and Losses: COVID-19 Leaves U.S. Hospitals in Financial CrisisFDA Goes After Unproven COVID-19 Antibody TestsDuring Droughts, Many Poor Americans Will Lack Clean Tap Water: StudyDid the Movie 'Joker' Reinforce Prejudice Against Mentally Ill?AHA News: How to Get the Most Out of Health AppsCoronavirus Conspiracy Theories Abound, and They Could Cause Real HarmAHA News: Health Emergency? Don't Hesitate to Get HelpAn Expert's Guide to Fact-Checking Coronavirus Info OnlineRacial, Ethnic Gaps in Insurance Put Moms, Babies at Risk: StudyCelebrity Suicides Spawn 'Copycat' Tragedies, Study Shows
The Doctor Gap: In Areas of Greatest Need, Primary Care Is a Team Effort">
The Doctor Gap: In Areas of Greatest Need, Primary Care Is a Team Effort
The Doctor Gap: Where Are All the Mental Health Care Providers?New, Graphic Health Warnings Coming for U.S. Cigarette PacksWith New Boost From Medicare, 'Telemedicine' Steps Up to Fight CoronavirusThe Doctor Gap: In Rural America, It's All Hands on DeckThe Doctor Gap: A Training Program for Country-Doc WannabesDon't Believe All the 'Science' on CBD ProductsMany Car Crash Deaths Involve Alcohol Levels Below Legal Limit: StudyThe Doctor Gap: Does America Have a Physician Shortage?12 Weeks of Paid Maternity Leave Benefits Everyone: StudyVaping Videos Soaring on YouTubeU.S. Blood Donors Needed in Face of COVID-19 CrisisIt's Tough for Clinical Trial Participants to Learn ResultsBogus Coronavirus 'Meds' Targeted by FDAOnly 1 in 5 Have Fast Access to State-of-the-Art Stroke CareOne Key Way to Curb Coronavirus Spread: More Paid Sick LeaveU.S. Drug Prices Have Risen Three Times Faster Than InflationU.S. Announces More Travel Restrictions as First Coronavirus Death ReportedIt's Not Medical Outcomes That Drive Patients' Hospital ReviewsChicago's Short-Lived 'Soda Tax' Cut Consumption, Boosted Health Care FundsSocial Media Stokes Myths About VaccinesBrand-Name Rx Rise After Docs Get Drug Company Perks: StudyAs Prices Rise for Parkinson's, Alzheimer's Meds, Patients Go WithoutRoll Up Your Sleeve and Donate Blood for Cancer PatientsShotguns Often Play Tragic Role in Rural Teens' Suicides: StudyPrice Hikes Have Patients Turning to Craigslist for Insulin, Asthma InhalersConsumers Waste Twice as Much Food as Experts ThoughtStricter Clean Air Laws Could Save Thousands of Lives a Year: StudyCaregivers Give Short Shrift to Their Own HealthMedicare Could Save Billions If Allowed to Negotiate Insulin Prices
Links
Related Topics

Health Insurance
Healthcare

Brand-Name Rx Rise After Docs Get Drug Company Perks: Study

HealthDay News
by -- Robert Preidt
Updated: Feb 21st 2020

new article illustration

FRIDAY, Feb. 21, 2020 (HealthDay News) -- American doctors prescribe more brand-name medications after they get a free lunch or other incentives from drug company marketers, a new study finds.

Researchers analyzed drug prescribing between 2013 and 2015 for a large sample of enrollees in Medicare Part D. The federal program, which subsidizes prescriptions for 37 million seniors and disabled people, accounts for nearly one-third of U.S. retail prescription drug sales.

That data was compared with a database in which drug companies report incentives provided to doctors, including meals, travel or continuing education expenses.

While those incentives tended to be modest -- 95% were meals, of which 80% were valued at less than $20 -- they were common and had an impact, according to the study.

More than 20% of Medicare Part D expenses on brand-name medications came from doctors who received an incentive related to a drug they prescribed. Nearly 30% of physicians got an incentive for at least one drug they prescribed during the study period.

"The prevalence of the practice implies that the financial impacts are economically large," the authors wrote in the working paper released Feb. 17 by the National Bureau of Economic Research.

Colleen Carey, an assistant professor of policy analysis and management at Cornell University, is the study's first author.

She and her colleagues estimated that for every additional dollar that drug companies spent on marketing visits, they could expect $2.64 more in drug revenue over the next year. That's a 164% return on investment.

That wasn't as high as previous estimates, which ranged from 200% to 1,700%, the researchers noted.

They also found that marketing visits by drug company reps don't lead doctors to prescribe higher-quality drugs, as the drug industry claims.

"We took seriously the claim that there is educational value to these marketing encounters," Carey said in a Cornell news release. "We just don't find any evidence for it."

More information

Santa Clara University has more on drug company gifts to doctors.




328 W. Claiborne St.
P.O. Box 964
Monroeville,
Alabama 36460
Tel: (251)575-4203
Fax:(251)575-9459


powered by centersite dot net